CYTARABINE

60759 reported adverse events

Drug classes: Nucleoside Metabolic Inhibitor [EPC]

These side effects are most commonly reported by patients taking CYTARABINE:

# Side effect Count
0 FEBRILE NEUTROPENIA 7783
1 OFF LABEL USE 5221
2 PYREXIA 4271
3 NEUTROPENIA 3744
4 DRUG INEFFECTIVE 3207
5 THROMBOCYTOPENIA 3005
6 SEPSIS 2989
7 DISEASE PROGRESSION 2800
8 MYELOSUPPRESSION 2421
9 PNEUMONIA 2390
See all common reactions for CYTARABINE

CYTARABINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY 235 0.2482
1 ACUTE MYELOID LEUKAEMIA RECURRENT 497 0.2313
2 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 502 0.2275
3 SECONDARY IMMUNODEFICIENCY 263 0.2165
4 NEUTROPENIC COLITIS 388 0.1874
5 FEBRILE BONE MARROW APLASIA 742 0.1744
6 PSEUDOMONAL SEPSIS 298 0.1700
7 MYELOPATHY 300 0.1578
8 LEUKAEMIA RECURRENT 263 0.1554
9 PARAINFLUENZAE VIRUS INFECTION 235 0.1543
See all enriched reactions for CYTARABINE